Sonic Healthcare Limited (ASX: SHL) - ETF Exposure

Current share price for SHL : $22.250 0.01 (0.04%)⁺

Sonic Healthcare (SHL) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is involved in provision of medical diagnostic services and the provision of administrative services and facilities to medical practitioners.

SHL General Information ⁺

ASX Code	SHL
Website	N/A
Industry/Sector	Health Care Services
Market Cap ($M)	10,996
SHL Share Price	$22.250
Day High	$22.350
Day Low	$22.070
Last Close	$22.240
SHL Share Price Movement	$0.01 ( 0.04% )

Prices as at 16:40, 7 Aug 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to SHL

As one of Australia's largest companies by market capitalisation, SHL is held across 36 ETFs spanning strategies that include health care services exposure . Its weighting in those funds means performance can have an outsized influence - when SHL moves, funds like IHD, FAIR, AUMF, ZYAU and MVW that hold it can move with it.

For more concentrated exposure, ETFs such as IHD (iShares S&P/ASX High Dividend Opportunities ETF) allocate about 2.3% to SHL , while the average exposure across all 36 ETFs that hold it is around 0.7% .

Top ETF holdings

iShares S&P/ASX High Dividend Opportunities ETF (IHD) ~ 2.3%
BetaShares Australian Sustainability Leaders ETF (FAIR) ~ 2.1%
ishares Edge MSCI Australia Multifactor ETF (AUMF) ~ 1.5%
Global X S&P/ASX 200 High Dividend ETF (ZYAU) ~ 1.5%
VanEck Australian Equal Weight ETF (MVW) ~ 1.4%

Last updated: ETF data and holdings as at 8 August 2026

Own SHL directly or through an ETF?

How does holding Sonic Healthcare Limited (SHL) shares directly compare to ETFs that include it?

	SHL Direct	IHD ASX	FAIR ASX	AUMF ASX	ZYAU ASX	MVW ASX
Holdings	1 company	55 holdings	83 holdings	127 holdings	59 holdings	74 holdings
SHL Weight	100%	2.3%	2.1%	1.5%	1.5%	1.4%
Diversification	Single Stock	Broad	Broad	Broad	Broad	Broad
Annual Cost	Brokerage only	0.23% p.a.	0.49% p.a.	0.3% p.a.	0.24% p.a.	0.35% p.a.
Approx. Yield	-	3.89%	2.98%	2.75%	4.14%	3.28%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not SHL's direct yield. Annual cost uses each ETF's MER.

SHL Exposure on $10,000 investment

How a $10,000 investment in Sonic Healthcare Limited (SHL) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Sonic Healthcare Limited (SHL)	Direct share	$22.250	1.78%	+$178	$10,178
iShares S&P/ASX High Dividend Opportunities ETF (IHD)	Equity - Australia Strategy	$17.730	1.43%	+$143	$10,143
BetaShares Australian Sustainability Leaders ETF (FAIR)	Equity - Australia Strategy	$19.390	2.97%	+$297	$10,297
ishares Edge MSCI Australia Multifactor ETF (AUMF)	Equity - Australia Strategy	$40.100	3.48%	+$348	$10,348
Global X S&P/ASX 200 High Dividend ETF (ZYAU)	Equity - Australia Strategy	$10.540	0.67%	+$67	$10,067
VanEck Australian Equal Weight ETF (MVW)	Equity - Australia	$39.910	3.50%	+$350	$10,350

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Sonic Healthcare Limited (SHL) ETFs

36 ETFs hold Sonic Healthcare Limited (SHL).

ETF	SHL Weight	MER	Yield
iShares S&P/ASX High Dividend Opportunities ETF (IHD)	2.3%	0.23%	3.89%
BetaShares Australian Sustainability Leaders ETF (FAIR)	2.1%	0.49%	2.98%
ishares Edge MSCI Australia Multifactor ETF (AUMF)	1.5%	0.3%	2.75%
Global X S&P/ASX 200 High Dividend ETF (ZYAU)	1.5%	0.24%	4.14%
VanEck Australian Equal Weight ETF (MVW)	1.4%	0.35%	3.28%
SPDR MSCI Australia Select High Dividend Yield Fund (SYI)	1.4%	0.2%	7.19%
VanEck MSCI Australian Sustainable Equity ETF (GRNV)	1.4%	0.35%	3.52%
Global X Australia ex Financials & Resources ETF (OZXX)	1.4%	0.25%	5.04%
ishares Edge MSCI Australia Minimum Volatility ETF (MVOL)	1%	0.3%	3%
Betashares Australian Ex-20 Portfolio Diversifier ETF (EX20)	1%	0.25%	2.72%

View all 36 ETFs

Sonic Healthcare Limited (SHL) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
Result	45¢	60%	4 Mar 2026	19 Mar 2026	-	-	-
HFResult	63¢	35%	3 Sep 2025	18 Sep 2025	-	-	-
Result	44¢	0%	5 Mar 2025	20 Mar 2025	-	-	-

See all dividends from Sonic Healthcare Limited (SHL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Sonic Healthcare Limited (SHL) price-sensitive announcements

SHL - CEO Presentation Half Year Results to 31 December 2025

Sonic Healthcare Limited reported its half-year results for the period ending 31 December

Sonic Healthcare Limited (SHL)
19 Feb 2026 | 8:50 AM

SHL - Media Release Half Year Results to 31 December 2025

Sonic Healthcare Limited reported a strong financial performance for the half-year ended 3

Sonic Healthcare Limited (SHL)
19 Feb 2026 | 8:49 AM

SHL - Half Yearly Report and Accounts

Sonic Healthcare Limited's half-year report for the period ending 31 December 2025 reveals

Sonic Healthcare Limited (SHL)
19 Feb 2026 | 8:42 AM

SHL - 2025 AGM CEO Presentations and Proxy Summary

During the 2025 Annual General Meeting, Sonic Healthcare Limited detailed its financial pe

Sonic Healthcare Limited (SHL)
20 Nov 2025 | 8:59 AM

Sonic Healthcare Limited (SHL) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$10,997	Release of Securities Subject to Voluntary Escrow	17 Jun 2026 4:08PM	$19.815	$22.250	risen by 12.29%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$10,997	Completion of Sale and Leaseback of Brisbane Hub Laboratory	15 Jun 2026 4:22PM	$19.940	$22.250	risen by 11.58%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$10,997	Change in substantial holding	13 Apr 2026 6:06PM	$19.720	$22.250	risen by 12.83%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$10,997	Notification regarding unquoted securities - SHL	2 Apr 2026 4:34PM	$19.980	$22.250	risen by 11.36%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$10,997	Change of Director's Interest Notice	9 Mar 2026 4:44PM	$21.970	$22.250	risen by 1.27%
Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID	Health Care	$10,997	Notification regarding unquoted securities - SHL	4 Mar 2026 4:43PM	$23.010	$22.250	fallen by 3.30%

SHL Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2026F	$601.94	$119.00	18.50%	23.88	109.00	3.84%	30.0%
2025F	$507.92	$100.41	-1.70%	28.30	108.00	3.80%	30.0%
2024A	$487.02	$102.10	-29.60%	29.37	106.00	3.54%	0.0%

SHL Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 F	2026 F	2024 A	2025 F	2026 F	2024 A	2025 F	2026 F
Australian Clinical Labs Limited (ACL)	$450M	-0.0336	0.0000	0.0000	13.3076	0.0000	0.0000	5.19%	0.00%	0.00%
Healius Limited (HLS)	$301M	-4.7068	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Integral Diagnostics Limited (IDX)	$832M	-1.3095	0.5666	0.1667	29.1123	18.5833	15.9286	2.91%	3.59%	3.14%
Sonic Healthcare Limited (SHL)	$10,992M	0.0625	0.1127	0.1161	20.8435	18.7316	16.7836	4.81%	4.92%	5.01%

SHL Directors

Name	Position	Start Date
Mr Christopher David Wilks	Chief Financial Officer, Finance Director	5 Dec 1989
Mr Neville Mitchell	Non-Executive Director	29 Sep 2017
Professor Suzanne Crowe	Non-Executive Director	6 Apr 2020
Professor Christine Constance Bennett	Non-Executive Director	26 Sep 2022
Ms Kathryn (Kate) Dianne Spargo	Non-Executive Director	1 Jul 2010
Ms Nicola Wakefield Evans	Non-Executive Director	10 Feb 2025
Dr Katharine Giles	Non-Executive Director	26 Sep 2022
Mr James Pacey Newcombe	Non-Executive Director	20 Nov 2025
Mr Mark Raymond Compton	Non-Executive Director, Non-Executive Chairman	7 Oct 2014

Sonic Healthcare Limited (SHL) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
16 Oct 2025	WAKEFIELD EVANS, Nicola	Buy	Indirect Shares	2,500	$21.780	$54,450.000
15 Oct 2025	GILES, Katharine	Buy	Indirect Shares	1,000	$21.169	$21,169.200
3 Oct 2025	GILES, Katharine	Buy	Indirect Shares	1,000	$21.720	$21,720.000

See all changes in directors' interest & trades for Sonic Healthcare Limited (SHL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

SHL Management

Name	Position
Paul Joseph Alexander	Company Secretary,Deputy Chief Financial Officer

SHL Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Sonic Healthcare Limited (SHL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
35,419,922 (7.17%)	State Street Corporation and subsidiaries
34,297,014 (6.94%)	BlackRock Group
28,857,614 (5.84%)	The Vanguard Group,Inc

SHL Calendar of Events

Date	Event
18 February 2027	Report (Interim)
23 September 2026	Report (Annual)
20 August 2026	Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us